Odyssey Therapeutics files for $100M IPO

Odyssey Therapeutics (ODTX), which is developing treatments for inflammatory bowel disease, has filed for a $100M initial public offering.

While Odyssey (ODTX) didn’t disclose any terms in its SEC filing, it indicated in a filing fee schedule that it was